New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 29, 2014
15:46 EDTNBYDoctor uses NovaBay product in flesh-eating disease treatment, SFGate says
Dr. John Crew has used NeutroPhase, a NovaBay Pharmaceuticals product approved for cleaning wounds, as part of a new technique he successfully implemented to treat necrotizing fasciitis, which is otherwise known as "flesh-eating disease," while trying to avoid the repeated surgeries typically associated with treatment of the condition, reported SFGate yesterday. Reference Link
News For NBY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 26, 2015
07:05 EDTNBYNovaBay signs Avenova distribution agreement with Cardinal Health
Subscribe for More Information
January 21, 2015
08:23 EDTNBYNovaBay to hold a conference call
Subscribe for More Information
January 20, 2015
07:06 EDTNBYNovaBay expanding sales force for Avenova
NovaBay Pharmaceuticals announced that it is expanding its sales force for its innovative eye care product Avenova from 15 sales representatives to 35 representatives. Ron Najafi, Ph.D., Chairman and CEO of NovaBay, commented, “We plan to further increase our sales force to more than 50 representatives by July, which will allow us to reach more of the estimated 30 million Americans who suffer from eyelid conditions. We estimate the market opportunity for Avenova at $500 million annually in the U.S. alone.”

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use